April 20, 2023
Ankura announces the addition of a dedicated Life Sciences team within its Disputes & Economics practice with two seasoned, senior professionals that bolster and expand the firm’s life sciences capabilities in the specific focus areas of: compliance, disputes, and investigations; regulatory (e.g., Food and Drug Administration); government pricing; intellectual property; supply chain operations; due diligence support for transactions and disputes; mergers, acquisitions, and divestitures and licensing; and clinical and manufacturing operations.
The Life Sciences team within Disputes & Economics will be led by Senior Managing Director David Berger who brings over 20 years of strategic leadership experience working with life sciences companies to advise on matters of compliance, regulatory, disputes and investigations, antitrust, intellectual property, mergers and acquisitions, and clinical, manufacturing and supply chain operations. Joining David is Senior Managing Director Katherine C. Norris who specializes in compliance investigations, disputes, and advisory matters with over 20 years of industry experience as a life sciences compliance officer, advisor, and expert witness.
Dorothy DeAngelis, Senior Managing Director and Disputes & Economics Healthcare and Life Sciences Practice lead, commented:
“With the addition of a Life Sciences team within Disputes & Economics, the vision for the continued expansion of services tailored for companies in the life sciences industry, in collaboration with our existing Ankura practice groups and experts, positions Ankura to provide end-to-end global integrated, multidisciplinary services to serve companies across the entire continuum of healthcare, from research and development to providers and payors. We are thrilled to have David and Katherine join Ankura.”